How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race
German biotech BioNTech SE worked on cancer treatments, and was developing an influenza vaccine with Pfizer Inc., when its founder, Ugur Sahin, led the company’s pivot to the coronavirus in January.